(Q37983094)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22324439%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

title

Silver nanoparticles: the powerful nanoweapon against multidrug-resistant bacteria (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22324439%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

0 references

0 references

multiple drug resistance

1 reference

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22324439%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Aniket Gade

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22324439%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

author name string

S D Deshmukh

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22324439%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

A P Ingle

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22324439%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

publication date

28 March 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22324439%20AND%20SRC:MED&resulttype=core&format=json

Journal of Applied Microbiology

22 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22324439%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

volume

112

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22324439%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22324439%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

page(s)

841-852

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22324439%20AND%20SRC:MED&resulttype=core&format=json

An Enzyme from Bacteria able to Destroy Penicillin

22 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2012.05253.X

Effect of silver on burn wound infection control and healing: review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2012.05253.X

Synthesis and antibacterial properties of silver nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2012.05253.X

Anti-inflammatory effect of topical nanocrystalline silver cream on allergic contact dermatitis in a guinea pig model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2012.05253.X

Fabrication of silver nanoparticles by Phoma glomerata and its combined effect against Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2012.05253.X

Use of aqueous silver to enhance inactivation of coliphage MS-2 by UV disinfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2012.05253.X

Comparative evaluation of silver-containing antimicrobial dressings and drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2012.05253.X

Characterisation of Salmonella spp. mutants produced by exposure to various fluoroquinolones

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2012.05253.X

Nanosilver: a nanoproduct in medical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2012.05253.X

The increasing use of silver-based products as antimicrobial agents: a useful development or a cause for concern?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2012.05253.X

Potential of old-generation antibiotics to address current need for new antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2012.05253.X

Fungus-mediated synthesis of silver nanoparticles and their activity against pathogenic fungi in combination with fluconazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2012.05253.X

Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2012.05253.X

Mechanisms of action and resistance of older and newer fluoroquinolones

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2012.05253.X

Antimicrobial effects of silver nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2012.05253.X

In vitro antimicrobial effect of the tissue conditioner containing silver nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2012.05253.X

Aminoglycosides: perspectives on mechanisms of action and resistance and strategies to counter resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2012.05253.X

Silver. I: Its antibacterial properties and mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2012.05253.X

Proteomic analysis of the mode of antibacterial action of silver nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2012.05253.X

Comparison of the in-vitro activities of the topical antimicrobials azelaic acid, nitrofurazone, silver sulphadiazine and mupirocin against methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2012.05253.X

New aspects of nanopharmaceutical delivery systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2012.05253.X

Mode of bactericidal action of silver zeolite and its comparison with that of silver nitrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2012.05253.X

The bactericidal effect of silver nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2012.05253.X

TREATMENT OF LARGE HUMAN BURNS WITH 0.5 PER CENT SILVER NITRATE SOLUTION.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2012.05253.X

Biosynthesis of silver nanoparticles from Staphylococcus aureus and its antimicrobial activity against MRSA and MRSE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2012.05253.X

Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2012.05253.X

Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the Gram-negative bacterium Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2012.05253.X

Antimicrobial activity of silver-containing dressings on wound microorganisms using an in vitro biofilm model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2012.05253.X

Resistance to beta-lactam antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2012.05253.X

Silver nanoparticles as a new generation of antimicrobials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2012.05253.X

Nanoparticles in energy technology: examples from electrochemistry and catalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2012.05253.X

Extracellular synthesis of silver bionanoparticles from Aspergillus clavatus and its antimicrobial activity against MRSA and MRSE

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2012.05253.X

Synthesis and effect of silver nanoparticles on the antibacterial activity of different antibiotics against Staphylococcus aureus and Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2012.05253.X

Silver nanoparticles fabricated in Hepes buffer exhibit cytoprotective activities toward HIV-1 infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2012.05253.X

Mechanisms of antimicrobial resistance in bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2012.05253.X

Topical delivery of silver nanoparticles promotes wound healing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2012.05253.X

Testing strategies to establish the safety of nanomaterials: conclusions of an ECETOC workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2012.05253.X

A model of antibiotic-resistant bacterial epidemics in hospitals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2012.05253.X

Bactericidal actions of a silver ion solution on Escherichia coli, studied by energy-filtering transmission electron microscopy and proteomic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2012.05253.X

Erratum to: Enhanced antibacterial effect of silver nanoparticles obtained by electrochemical synthesis in poly(amide-hydroxyurethane) media

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2012.05253.X

Medical applications of nanoparticles in biological imaging, cell labeling, antimicrobial agents, and anticancer nanodrugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2012.05253.X

Presenting Vancomycin on Nanoparticles to Enhance Antimicrobial Activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2012.05253.X